Tick Bites
9
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (9)
Evaluating the Impacts of Informal Tick and Tickborne Disease Educational Tools on Children
The Tick App: Changing Behaviors With Educational Messaging
Acquired Tick Resistance in Naturally Exposed Participants
The Uninfected Ixodes Scapularis Human Tick Challenge Model
Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and Meningoencephalitis
Fever After Tick Bite Study
Tick-borne Illness and Clothing Study
Tick-borne Illness and Clothing Study of Rhode Island
Determining the Complete Protection Time of an Insect Repellent With 30% Citriodiol® Against Three Species of Ticks.